Mika Derynck

First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors

Clinical Cancer Research · 2015 · 277 citations

Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes

Proceedings of the National Academy of Sciences of the United States of America · 2004 · 276 citations